Table 3 Hospital survivors versus non-survivorsA,B
Survivors, n=39 (16.5%) | Non-survivors, n=197 (83.5%) | p-value | |
|---|---|---|---|
Male gender (%) | 30 (76.9%) | 154 (78.2%) | 0.863 |
Age (years) | 63 (14.9) | 62 (15.4) | 0.88 |
Weight (kg) | 88.6 (14.2) | 92.8 (26.3) | 0.33 |
MB bolus only | 25 (64.1%) | 115 (58.4%) | 0.51 |
MB bolus and infusion | 14 (39.5%) | 72 (36.6%) | 0.94 |
MB bolus dose (mg/kg) | 1.7 (0.42) | 1.7 (0.45) | 0.97 |
MB drip rate (mg/kg/hr) | 0.39 (0.22) | 0.48 (0.21) | 0.15 |
MB drip duration (hours) | 13.9 (10.9) | 14.3 (12.3) | 0.91 |
NE at 1 hours after MB (mcg/min) | 34.5 (33) | 61 (42) | 0.0003 |
NE at 2 hours after MB (mcg/min) | 27.7 (18.2) | 57 (40.5) | <0.0001 |
>1 MB bolus administered (%) | 7 (17.9%) | 32 (16.2%) | 0.79 |
CRRT (%) | 16 (41%) | 137 (69.5%) | <0.0001 |
IV fluids administered in first 24 hours (mL) | 2352 (3096) | 2951 (3186) | 0.28 |
ICU LOS (days) | 13.9 (21.9) | 11.5 (21.8) | 0.53 |
Hospital LOS (days) | 28.8 (28.5) | 15.3 (25.9) | 0.004 |
SOFA Score | 11.69 (2.2) | 13.35 (2.9) | 0.0007 |